文献速递肝胆胰外科围术期管理与 ERAS

门静脉栓塞术后肝静脉压力梯度可准确预测未来残肝肥大

Hepatic venous pressure gradient after portal vein embolization: An accurate predictor of future liver remnant hypertrophy.
PubMed 文献 · Surgery · 2018-05-10

PVE后HVPG是预测残肝肥大未达30%的最准确参数(c-statistic 0.882,95%CI 0.727-1.000,P<0.001),cut-off值8 mm Hg时灵敏度91%、特异度80%。

要点

  • PVE后HVPG可准确预测残肝肥大不足,cut-off值8 mm Hg。
  • PVE后HVPG与既往化疗是残肝肥大受损的预测因素。
  • PVE后HVPG有助于早期识别需更强促增生措施的患者。

核心结论

  • PVE后HVPG是一种简单、可重复的工具,能准确预测PVE后残肝肥大,并早期识别可能受益于更积极促残肝肥大措施的患者。

研究设计与样本

  • 通过直接穿刺门静脉与下腔静脉,同步测量PVE前后门静脉压力与肝静脉压力梯度。

主要发现

  • PVE后中位门静脉压力从15(9-24)mm Hg升至19(10-27)mm Hg,HVPG从5(0-12)mm Hg升至8(0-14)mm Hg。
  • PVE前中位残肝体积为513(299-933)mL,PVE后3周为724(499-1279)mL,中位肥大35%(7.4-83.6)。
  • PVE后HVPG是预测残肝未达30%肥大的最准确参数(c-statistic 0.882,95%CI 0.727-1.000,P<0.001)。
  • 多因素分析显示PVE后HVPG与既往化疗是残肝肥大受损的预测因素。

关键数值与推荐

  • PVE后HVPG cut-off值8 mm Hg预测残肝未达30%肥大:灵敏度91%(95%CI 57%-99%),特异度80%(95%CI 52%-96%),阳性预测值77%(95%CI 46%-95%),阴性预测值92.3%(95%CI 64.0%-99.8%)。

临床怎么用

  • PVE后测量HVPG可用于评估残肝肥大失败风险,指导是否需更积极促增生干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of portal hemodynamic variations after portal vein embolization on liver regeneration remains unknown. We studied the correlation between the parameters of hepatic venous pressure measured before and after portal vein embolization and future hypertrophy of the liver remnant after portal vein embolization. METHODS: Between 2014 and 2017, we reviewed patients who were eligible for major hepatectomy and who had portal vein embolization. Patients had undergone simultaneous measurement of portal venous pressure and hepatic venous pressure gradient before and after portal vein embolization by direct puncture of portal vein and inferior vena cava. We assessed these parameters to predict future liver remnant hypertrophy. RESULTS: Twenty-six patients were included. After portal vein embolization, median portal venous pressure (range) increased from 15 (9-24) to 19 (10-27) mm Hg and hepatic venous pressure gradient increased from 5 (0-12) to 8 (0-14) mm Hg. Median future liver remnant volume (range) was 513 (299-933) mL before portal vein embolization versus 724 (499-1279) mL 3 weeks after portal vein embolization, representing a 35% (7.4-83.6) median hypertrophy. Post-portal vein embolization hepatic venous pressure gradient was the most accurate parameter to predict failure of future liver remnant to reach a 30% hypertrophy (c-statistic: 0.882 [95% CI: 0.727-1.000], P < 0.001). A cut-off value of post-portal vein embolization hepatic venous pressure gradient of 8 mm Hg showed a sensitivity of 91% (95% CI: 57%-99%), specificity of 80% (95% CI: 52%-96%), positive predictive value of 77% (95% CI: 46%-95%) and negative predictive value of 92.3% (95% CI: 64.0%-99.8%). On multivariate analysis, post-portal vein embolization hepatic venous pressure gradient and previous chemotherapy were identified as predictors of impaired future liver remnant hypertrophy. CONCLUSION: Post-portal vein embolization hepatic venous pressure gradient is a simple and reproducible tool which accurately predicts future liver remnant hypertrophy after portal vein embolization and allows early detection of patients who may benefit from more aggressive procedures inducing future liver remnant hypertrophy. (Surgery 2018;143:1-2.).

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Mohkam K, Rode A, Darnis B, et al. Hepatic venous pressure gradient after portal vein embolization: An accurate predictor of future liver remnant hypertrophy. Surgery. 2018. PMID: 29753461. doi:10.1016/j.surg.2018.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。